CHSY3 and gastric cancer: Notably, CHSY3 expression was associated with a favorable outcome in GC patients, and this study showed that increased CHSY3 expression was linked to a worse prognosis in the TCGA GC cohort (OS: HR = 1.58, p = 0.007; DSS: HR=1.54, p=0.046) (Figures 2D, E).